Editorial: Is it time to include oral vancomycin in therapeutic guidelines for primary sclerosing cholangitis-associated inflammatory bowel disease?
ALIMENTARY PHARMACOLOGY & THERAPEUTICS(2024)
摘要
LINKED CONTENT This article is linked to Ricciuto et al paper. To view this article, visit
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要